Evolving regulations in sterile manufacturing requires innovation, market knowledge, and investment. How can drug ...

With its active pharmaceutical ingredient (API) facility “in a state of disrepair,” manufacturer Aspen Biopharma Labs’ operations have ground to a halt in the U.S., according to a recent FDA reprim | ...

Created in 1992, the FDA's accelerated approval pathway allows an initial approval of drugs for serious or life-threatening ...

Learn more about whether Medpace Holdings, Inc. or Repligen Corporation is a better investment based on AAII's A+ Investor ...

Arialief offers a satisfaction guarantee, allowing customers to try the product risk-free. If users do not experience the ...

The agency cited quality issues at facilities testing Dexcom’s G6 and G7 monitors, including inadequate validation and risk ...

Evofem Biosciences, Inc. (OTCQB: EVFM) (Evofem or the Company) today announced that it has entered into a License and Supply ...

On track for multiple clinical updates through mid-2026, including further progress from two ongoing clinical programs and initiation of ...

On track for multiple clinical updates through mid-2026, including further progress from two ongoing clinical programs and initiation of therapeutic dosing of potential new medicine, all based on our ...

Ernst emphasized the strategic transformation of Tivic into a diversified therapeutics company, combining biologic and bioelectronic approaches to address immune dysregulation. This includes ...

Explore how Industrial Intelligence revolutionizes operations by integrating IoT, AI, and big data, enhancing efficiency and ...

Orbit Phase 3 study of setrusumab in osteogenesis imperfecta progressing toward second interim analysis, expected mid-2025Alvelestat granted ...